NEW DELHI (Reuters) – Pfizer is in talks with the Indian government over supplies of its COVID-19 vaccine, the U.S. drugmaker said on Tuesday, as New Delhi scrambles to bridge shortfalls, having pledged to fast-track approvals for overseas vaccines.
“Pfizer remains committed to continuing our engagement with the government of India towards making the Pfizer BioNTech Covid-19 vaccine available for use in the country,” a spokeswoman told Reuters in an e-mailed statement.
Last week, Reuters reported Pfizer was in talks with the government to defuse tension over supplies.
(Reporting by Neha Arora; Editing by Clarence Fernandez)
